We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Bayer, Novartis Near Settlement Over MS Drug

Law360 (January 12, 2007, 12:00 AM EST) -- Pharmaceutical companies Novartis AG and Bayer AG may soon be settling their differences over the production and marketing of multiple sclerosis drug Betaseron.

The companies jointly asked a court in California to postpone a deadline from Jan. 16 to Feb. 20 so they could continue settlement talks, the Financial Times Deutschland reported.

Currently, Bayer unit Schering and Novartis unit Chiron have a licensing deal over Betaseron set to end in 2008. Chiron exclusively produces the drug in the United States for Schering and receives a 22.5%...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.